Antonio Muñoz
- Democratic
Primary
Amends the Pharmacy Practice Act. Provides that a pharmacist may substitute a prescription biosimilar product for a prescribed biological product under certain circumstances. Provides that the Board shall adopt rules for compliance with these provisions. Effective immediately.
No votes to display
Session Sine Die
Pursuant to Senate Rule 3-9(b) / Referred to Assignments
Rule 2-10 Committee/3rd Reading Deadline Established As November 7, 2013
Rule 2-10 Third Reading Deadline Established As May 31, 2013
Rule 2-10 Third Reading Deadline Established As May 3, 2013
Second Reading
Placed on Calendar Order of 3rd Reading April 25, 2013
Placed on Calendar Order of 2nd Reading March 21, 2013
Do Pass Executive; 011-003-000
Sponsor Removed Sen. Steven M. Landek
Postponed - Executive
Added as Co-Sponsor Sen. Dan Kotowski
Sponsor Removed Sen. Mike Jacobs
Added as Co-Sponsor Sen. Mattie Hunter
Sponsor Removed Sen. William Delgado
Assigned to Executive
Added as Co-Sponsor Sen. Steven M. Landek
Added as Co-Sponsor Sen. William Delgado
Added as Co-Sponsor Sen. Mike Jacobs
Added as Co-Sponsor Sen. David Koehler
First Reading
Added as Chief Co-Sponsor Sen. Melinda Bush
Added as Chief Co-Sponsor Sen. Pamela J. Althoff
Added as Chief Co-Sponsor Sen. Iris Y. Martinez
Referred to Assignments
Filed with Secretary by Sen. Antonio Muñoz
| Bill Text Versions | Format |
|---|---|
| Introduced | HTML |
| Document | Format |
|---|---|
| No related documents. |
Data on Open States is updated periodically throughout the day from the official website of the Illinois General Assembly.
If you notice any inconsistencies with these official sources, feel free to file an issue.